Antidepressants may have to fight for Part D coverage

Share this article:

The Centers for Medicare and Medicaid Services (CMS) is proposing a new Part D access rule for immunosuppressants and antidepressants that would no longer require every drug in every class to have a place on the formulary, BioCentury reports. These two drug classes have been part of what's considered a protected class in Medicare Part D, a category which includes anticonvulsants, antineoplastics, antipsychotics and antiretrovirals.

The proposed rule says the remaining four classes would still be protected. The proposed change could give payers more leverage in rebate negotiations with pharmaceutical firms—insurers have claimed, the rule notes, that the protected status means companies have no incentive to lower prices because the current rule secures Part D formulary status.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.